OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection
Michael Freeley, Aideen Long
Biochemical Journal (2013) Vol. 455, Iss. 2, pp. 133-147
Open Access | Times Cited: 51
Michael Freeley, Aideen Long
Biochemical Journal (2013) Vol. 455, Iss. 2, pp. 133-147
Open Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Martin P. Stewart, Róbert Langer, Klavs F. Jensen
Chemical Reviews (2018) Vol. 118, Iss. 16, pp. 7409-7531
Open Access | Times Cited: 594
Martin P. Stewart, Róbert Langer, Klavs F. Jensen
Chemical Reviews (2018) Vol. 118, Iss. 16, pp. 7409-7531
Open Access | Times Cited: 594
Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation
Shiyong Li, Yang Liu, Cong‐Fei Xu, et al.
Journal of Controlled Release (2016) Vol. 231, pp. 17-28
Closed Access | Times Cited: 193
Shiyong Li, Yang Liu, Cong‐Fei Xu, et al.
Journal of Controlled Release (2016) Vol. 231, pp. 17-28
Closed Access | Times Cited: 193
Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
Srinivas Ramishetti, Ranit Kedmi, Meir Goldsmith, et al.
ACS Nano (2015) Vol. 9, Iss. 7, pp. 6706-6716
Closed Access | Times Cited: 171
Srinivas Ramishetti, Ranit Kedmi, Meir Goldsmith, et al.
ACS Nano (2015) Vol. 9, Iss. 7, pp. 6706-6716
Closed Access | Times Cited: 171
RNA Nanotechnology-Mediated Cancer Immunotherapy
Yao‐Xin Lin, Yì Wáng, Sara Blake, et al.
Theranostics (2019) Vol. 10, Iss. 1, pp. 281-299
Open Access | Times Cited: 139
Yao‐Xin Lin, Yì Wáng, Sara Blake, et al.
Theranostics (2019) Vol. 10, Iss. 1, pp. 281-299
Open Access | Times Cited: 139
Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles
Enping Hong, Justin R. Halman, Ankit Shah, et al.
Nano Letters (2018) Vol. 18, Iss. 7, pp. 4309-4321
Open Access | Times Cited: 113
Enping Hong, Justin R. Halman, Ankit Shah, et al.
Nano Letters (2018) Vol. 18, Iss. 7, pp. 4309-4321
Open Access | Times Cited: 113
Physical and chemical profiles of nanoparticles for lymphatic targeting
Xiyu Ke, Gregory P. Howard, Haoyu Tang, et al.
Advanced Drug Delivery Reviews (2019) Vol. 151-152, pp. 72-93
Closed Access | Times Cited: 108
Xiyu Ke, Gregory P. Howard, Haoyu Tang, et al.
Advanced Drug Delivery Reviews (2019) Vol. 151-152, pp. 72-93
Closed Access | Times Cited: 108
MicroRNA-125a-Loaded Polymeric Nanoparticles Alleviate Systemic Lupus Erythematosus by Restoring Effector/Regulatory T Cells Balance
Jiali Zhang, Chuanrong Chen, Hao Fu, et al.
ACS Nano (2020) Vol. 14, Iss. 4, pp. 4414-4429
Closed Access | Times Cited: 75
Jiali Zhang, Chuanrong Chen, Hao Fu, et al.
ACS Nano (2020) Vol. 14, Iss. 4, pp. 4414-4429
Closed Access | Times Cited: 75
Development of mRNA Lipid Nanoparticles: Targeting and Therapeutic Aspects
Yaping Liu, Yingying Huang, Guantao He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10166-10166
Open Access | Times Cited: 14
Yaping Liu, Yingying Huang, Guantao He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10166-10166
Open Access | Times Cited: 14
Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells
Le Li, Maider Muñoz‐Culla, Unai Carmona, et al.
Biomaterials (2016) Vol. 98, pp. 143-151
Open Access | Times Cited: 85
Le Li, Maider Muñoz‐Culla, Unai Carmona, et al.
Biomaterials (2016) Vol. 98, pp. 143-151
Open Access | Times Cited: 85
Comparing photoporation and nucleofection for delivery of small interfering RNA to cytotoxic T cells
Laura Wayteck, Ranhua Xiong, Kevin Braeckmans, et al.
Journal of Controlled Release (2017) Vol. 267, pp. 154-162
Closed Access | Times Cited: 71
Laura Wayteck, Ranhua Xiong, Kevin Braeckmans, et al.
Journal of Controlled Release (2017) Vol. 267, pp. 154-162
Closed Access | Times Cited: 71
Non-viral transfection technologies for next-generation therapeutic T cell engineering
Laurens Raes, Stefaan C. De Smedt, Koen Raemdonck, et al.
Biotechnology Advances (2021) Vol. 49, pp. 107760-107760
Closed Access | Times Cited: 49
Laurens Raes, Stefaan C. De Smedt, Koen Raemdonck, et al.
Biotechnology Advances (2021) Vol. 49, pp. 107760-107760
Closed Access | Times Cited: 49
Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment
Chunxiong Zheng, Jiabin Zhang, Hon Fai Chan, et al.
Small Methods (2021) Vol. 5, Iss. 5
Closed Access | Times Cited: 42
Chunxiong Zheng, Jiabin Zhang, Hon Fai Chan, et al.
Small Methods (2021) Vol. 5, Iss. 5
Closed Access | Times Cited: 42
Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells
Jiaxuan Chen, Aleksandra Ellert‐Miklaszewska, Stefano Garofalo, et al.
Nature Protocols (2020) Vol. 16, Iss. 1, pp. 327-351
Open Access | Times Cited: 39
Jiaxuan Chen, Aleksandra Ellert‐Miklaszewska, Stefano Garofalo, et al.
Nature Protocols (2020) Vol. 16, Iss. 1, pp. 327-351
Open Access | Times Cited: 39
Overcoming T Cell Exhaustion via Immune Checkpoint Modulation with a Dendrimer‐Based Hybrid Nanocomplex
Yue Gao, Zhijun Ouyang, Chao Yang, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 19
Closed Access | Times Cited: 38
Yue Gao, Zhijun Ouyang, Chao Yang, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 19
Closed Access | Times Cited: 38
Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery
Ricarda C. Steffens, Ernst Wagner
Pharmaceutical Research (2022) Vol. 40, Iss. 1, pp. 47-76
Open Access | Times Cited: 24
Ricarda C. Steffens, Ernst Wagner
Pharmaceutical Research (2022) Vol. 40, Iss. 1, pp. 47-76
Open Access | Times Cited: 24
The impact of Nucleofection® on the activation state of primary human CD4 T cells
Mingce Zhang, Zhengyu Ma, Nithianandan Selliah, et al.
Journal of Immunological Methods (2014) Vol. 408, pp. 123-131
Open Access | Times Cited: 48
Mingce Zhang, Zhengyu Ma, Nithianandan Selliah, et al.
Journal of Immunological Methods (2014) Vol. 408, pp. 123-131
Open Access | Times Cited: 48
Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes
Shoshy Mizrahy, Inbal Hazan‐Halevy, Niels Dammes, et al.
Molecular Therapy (2017) Vol. 25, Iss. 7, pp. 1491-1500
Open Access | Times Cited: 48
Shoshy Mizrahy, Inbal Hazan‐Halevy, Niels Dammes, et al.
Molecular Therapy (2017) Vol. 25, Iss. 7, pp. 1491-1500
Open Access | Times Cited: 48
Electroporation Knows No Boundaries: The Use of Electrostimulation for siRNA Delivery in Cells and Tissues
Christin Luft, Robin Ketteler
SLAS DISCOVERY (2015) Vol. 20, Iss. 8, pp. 932-942
Open Access | Times Cited: 43
Christin Luft, Robin Ketteler
SLAS DISCOVERY (2015) Vol. 20, Iss. 8, pp. 932-942
Open Access | Times Cited: 43
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
Danielle Brito e Cunha, Ana Frederico, Tamiris Azamor, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 575-575
Open Access | Times Cited: 22
Danielle Brito e Cunha, Ana Frederico, Tamiris Azamor, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 575-575
Open Access | Times Cited: 22
Non-viral siRNA delivery to T cells: Challenges and opportunities in cancer immunotherapy
Jelter Van Hoeck, Kevin Braeckmans, Stefaan C. De Smedt, et al.
Biomaterials (2022) Vol. 286, pp. 121510-121510
Closed Access | Times Cited: 20
Jelter Van Hoeck, Kevin Braeckmans, Stefaan C. De Smedt, et al.
Biomaterials (2022) Vol. 286, pp. 121510-121510
Closed Access | Times Cited: 20
Alternative approaches for the treatment of airway diseases: focus on nanoparticle medicine
Elaref Ratemi, A. Sultana Shaik, Achraf Al Faraj, et al.
Clinical & Experimental Allergy (2016) Vol. 46, Iss. 8, pp. 1033-1042
Closed Access | Times Cited: 31
Elaref Ratemi, A. Sultana Shaik, Achraf Al Faraj, et al.
Clinical & Experimental Allergy (2016) Vol. 46, Iss. 8, pp. 1033-1042
Closed Access | Times Cited: 31
Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles
Srinivas Ramishetti, Dalit Landesman‐Milo, Dan Peer
Journal of drug targeting (2016) Vol. 24, Iss. 9, pp. 780-786
Closed Access | Times Cited: 28
Srinivas Ramishetti, Dalit Landesman‐Milo, Dan Peer
Journal of drug targeting (2016) Vol. 24, Iss. 9, pp. 780-786
Closed Access | Times Cited: 28
Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment
Emily B. Harrison, Salma H. Azam, Chad V. Pecot
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 28
Emily B. Harrison, Salma H. Azam, Chad V. Pecot
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 28
Overcoming T Cell Exhaustion in Tumor Microenvironment via Immune Checkpoint Modulation with Nano‐Delivery Systems for Enhanced Immunotherapy
Xin Huang, Weiyue Zhang
Small Methods (2023) Vol. 8, Iss. 8
Closed Access | Times Cited: 8
Xin Huang, Weiyue Zhang
Small Methods (2023) Vol. 8, Iss. 8
Closed Access | Times Cited: 8
Engineering lymphocytes with RNAi
Srinivas Ramishetti, Dan Peer
Advanced Drug Delivery Reviews (2018) Vol. 141, pp. 55-66
Closed Access | Times Cited: 27
Srinivas Ramishetti, Dan Peer
Advanced Drug Delivery Reviews (2018) Vol. 141, pp. 55-66
Closed Access | Times Cited: 27
